Search for Schering-Plough Corp and
  1. December 12, 2012

    Bausch & Lomb put up for sale at $10bn

    Warburg Pincus has kicked off the planned sale of US contact-lenses maker Bausch & Lomb with a price tag of more than $10bn,...

  2. February 29, 2012

    Insider trading probe broadens to pharma stocks

    The US investigation into insider dealing on Wall Street has broadened to include trading of biotechnology and...

  1. October 28, 2011

    Merck earnings rise on HPV vaccine success

    Merck, the world's second-largest drugmaker by revenues, reported a surge in its third-quarter profits on Friday, lifted by...

  2. July 29, 2011

    Merck looks to cut up to 13,000 jobs

    Merck, the US drug company, will cut as many as 13,000 jobs, or 13 per cent of its workforce, as it looks to slash costs and...

  3. July 18, 2011

    Bribery: Lines less blurred

    Slush funds distributed via travel agencies to pay for sightseeing trips abroad. Shopping bags stuffed with bank notes...

  4. June 27, 2011

    Discovery is running ahead of delivery

    When Pfizer, the US drugs company, announced the closure of its landmark research and development centre at Sandwich in the...

  5. May 9, 2011

    Sanofi eyes assets for animal health unit

    Sanofi-Aventis plans to cut costs and expand its animal health business through acquisitions as it fully integrates Merial...

  6. April 16, 2011

    J&J leaps amid Swiss talks reports

    Johnson & Johnson shares jumped in after-hours trading on Friday on reports that the US healthcare company was in talks to...

  7. April 16, 2011

    Merck to pay J&J $500m over arthritis drug

    Merck is to pay Johnson & Johnson $500m and relinquish foreign sales that last year generated $840m, in a settlement of its...

  8. April 14, 2011

    Elliott keeps up pressure on Actelion

    Rebel investors stepped up their criticism of Actelion on Thursday as they pursued efforts to appoint new board members to...

  9. March 22, 2011

    Merck and Sanofi scrap joint venture

    Merck and Sanofi-Aventis have abandoned plans to create the world’s largest animal health company, scrapping a joint venture...

  10. January 21, 2011

    JPMorgan adds legal weight in top-tier reshuffle

    JPMorgan has hired Jim Woolery, a prominent deal lawyer at Cravath, Swaine & Moore, to co-head its North American mergers...

  11. November 30, 2010

    Incoming Merck chief to focus on pricing

    The incoming head of Merck has pledged to focus on “demonstrating value” in pricing as he oversees the launch of a series of...

  12. November 17, 2010

    Roche to slash staff numbers by 6%

    Roche will cut 4,800 jobs – or 6 per cent of its workforce – to save SFr2.4bn ($2.4bn) a year, as the Swiss pharmaceuticals...

  13. October 25, 2010

    Office Depot chief to quit after SEC penalty

    Office Depot, the US office supplies retailer, is to resign, it emerged less than a week after the company agreed to pay a...

  14. FT Alphaville

    July 21, 2010

    Reckitt finally makes its move for SSL

    That’s a relief. After what feels like a decade of speculation, Reckitt Benckiser has finally got round to bidding for Durex...

  15. FT Alphaville

    July 21, 2010

    Reckitt snaps up SSL for £2.5bn

    Reckitt Benckiser has agreed to buy SSL International in a £2.54bn ($3.87bn) deal that would give it ownership of the Durex...

  16. March 9, 2010

    Sanofi joins Merck in animal health venture

    Sanofi-Aventis of France on Tuesday paid $1bn to Merck of the US as part of a deal to establish a joint venture which will...

  17. February 10, 2010

    Sanofi gears up for $1bn deal with Merck

    Sanofi-Aventis is gearing up to pay about $1bn to create one of the world’s largest animal health companies through a joint...

  18. December 27, 2009

    A decade of ups and downs on the M&A carousel

    In January 2000, as Steve Case unveiled the all-stock $164bn merger between AOL and Time Warner, the AOL chief executive...

  19. November 22, 2009

    Sanofi chief lays out distinctive strategy

    The chief executive of Sanofi-Aventis has criticised the past dominance of science over commerce in the French...

  20. October 22, 2009

    Cost cuts buoy drug groups’ profits

    Pharmaceutical companies maintained profits in the third quarter, helped by cost controls, but sales gains were modest....

  21. October 19, 2009

    Corporate Diary

    TODAY Earnings Aluminum Corporation Of China FY -Rmb0.13 (Rmb0) Apple Q4 $1.42 ($1.26) Bank of China FY Rmb0.28 (Rmb0.25)...

  22. September 30, 2009

    Pharmaceuticals: Same end, entirely different means

    Their headquarters stand less than two kilometres apart, on opposite sides of the river Rhine in the city of Basel in...

  23. September 21, 2009

    Merck eyes larger Merial

    Merck, the US pharmaceutical group, has given the strongest indication yet of its intention to recreate an enlarged joint...

  24. September 20, 2009

    Merck eyes larger Merial

    Merck, the US pharmaceutical group, has given the strongest indication yet of its intention to recreate an enlarged joint...

  25. September 17, 2009

    Merck and Wellcome Trust in vaccine alliance

    Merck on Thursday announced a ground-breaking £90m ($148.6m) partnership with the Wellcome Trust to develop vaccines for the...

  26. August 14, 2009

    Remedy for a malady

    In a London gentlemen’s club where the pre-eminent scientific questions of the 19th century were often debated, a group of...

  27. July 31, 2009

    Sanofi to take control of Merial

    Sanofi-Aventis, the French pharmaceutical group, is to buy out joint-venture partner Merck's stake in Merial, the animal...

  28. July 31, 2009

    Sanofi to take control of Merial

    Sanofi-Aventis, the pharmaceutical group, is to buy out joint venture partner Merck's stake in Merial, the animal health...

  29. July 30, 2009

    Telecoms sound positive tone for Europe

    European equities rose to their highest level for the year on Thursday amid thin holiday season trading volumes as a string...

  30. FT Alphaville

    July 30, 2009

    Sanofi's $4bn Merial acquisition

    Deal making is heating up in the world of big pharma, with French drugs group Sanofi-Aventis on Thursday confirming that it...

  31. July 30, 2009

    Sanofi-Aventis / Merial

    First there were pet therapists. Then came yoga for dogs. Now there is even a dedicated pet airline, Pet Airways, which...

  32. July 30, 2009

    Sanofi buys full control of Merial from Merck

    Sanofi-Aventis, the French pharmaceutical group, is to buy out joint venture partner Merck’s stake in Merial, the animal...

  33. July 22, 2009

    Pfizer

    Shareholders watching drugmakers approach the precipice have two choices: get off now at subpar valuations or hang on for a...

  34. July 21, 2009

    Merck profits hampered by stronger dollar

    Merck and Schering-Plough, the two pharmaceuticals on track to merge by the end of the year, on Tuesday reported...

  35. July 21, 2009

    Late rally lifts US stocks

    A late rally for US stocks saw the markets build on Monday’s impressive gains on Tuesday and set new highs for the year,...

  36. July 17, 2009

    Bill Gates' investment manager

    As the man who runs the Bill and Melinda Gates Foundation Trust, Michael Larson is an unlikely investor in JJB Sports. The...

  37. June 27, 2009

    Merck and Sanofi close to settling Merial deal

    Merck of the US is close to restructuring its lucrative animal medicines assets in a wide-ranging deal likely to be...

  38. June 26, 2009

    Merck and Sanofi close to settling Merial deal

    Merck of the US is close to restructuring its lucrative animal medicines assets in a wide-ranging deal likely to be...

Search for Schering-Plough Corp and